Page 6 - Early Phase News Today

DURHAM, N.C.--(BUSINESS WIRE)--$DTIL #ARCUS--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that an abstract on the effective cell dose and functional attributes of the company’s le...

WALTHAM, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) --  TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...

Die S3-Leitlinie »Empfehlungen zur stationären Therapie von Patienten mit Covid-19« wurde aktualisiert. Es gibt vor allem Änderungen ...

Emittent / Herausgeber: Bit Capital GmbH / Schlagwort(e): Marktbericht/Stellungnahme Bit Capital GmbH: Was kommt nach dem Crypto-Crash? 15.09.2022 / 07:55 CET/CEST Für den Inhalt

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented new research from its psychiatry portfolio at the 2022 Congress of the Schizophrenia International...

- Detailed Results Presented From ENLIGHTEN-Early Phase 3b Study of LYBALVI in Patients Early in Illness - DUBLIN, April 7, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented

For some patients, CBD oil products have proven valuable in treating inflammation and lupus. Find out the best CBD oils for lupus in 2023.

Track breaking Personality Disorder headlines on NewsNow: the one-stop shop for Personality Disorder news

Toronto, ON (PRWEB) December 02, 2021 -- To overcome the challenges faced during the drug development lifecycle, a thorough assessment of quality systems

Aktuelle Corona-News aus Deutschland & weltweit: RKI meldet über 12.000 Neuinfektionen - Inzidenz ist gestiegen. Karl Lauterbach ist besorgt.